Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-11 Sale | 2024-12-13 6:41 pm | CERO THERAPEUTICS HOLDINGS INC. | CERO | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner | 5,957,250 | $0.06722 | $400,456 | 13,005,169 (Indirect) | View |
| 2024-12-06 Sale | 2024-12-10 8:44 pm | CERO THERAPEUTICS HOLDINGS INC. | CERO | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner | 3,658,364 | $0.10479 | $383,370 | 18,962,419 (Indirect) | View |
| 2024-09-25 Sale | 2024-11-20 4:04 pm | CERO THERAPEUTICS HOLDINGS INC. | CERO | SLOAN STUART M 10% Owner | 532,486 | $0.1043 | $55,538 | 21,067,956 (Indirect) | View |
| 2024-10-10 Sale | 2024-11-14 8:14 pm | CERO THERAPEUTICS HOLDINGS INC. | CERO | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner | 3,250,000 | $0.1 | $325,000 | 22,620,783 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-30 Option Award | 2025-06-02 5:09 pm | N/A 2035-05-29 | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 9,326 | $0 | 9,326 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 5:08 pm | N/A 2035-05-29 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director | 9,326 | $0 | 9,326 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 5:06 pm | N/A 2035-05-29 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director | 9,326 | $0 | 9,326 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 5:05 pm | N/A 2035-05-29 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director | 11,693 | $0 | 11,693 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 5:04 pm | N/A 2035-05-29 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO | 61,843 | $0 | 61,842 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 5:02 pm | N/A 2035-05-29 | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 122,549 | $0 | 122,549 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 5:01 pm | N/A 2035-05-29 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Pierce Kristen Chief Development Officer | 154,841 | $0 | 154,841 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-02 4:57 pm | N/A 2035-05-29 | CERO THERAPEUTICS HOLDINGS INC. | CERO | KUCHARCHUK ANDREW ALBERT Chief Financial Officer | 152,500 | $0 | 152,500 (Direct) | View |
Ownership(A) | 2025-05-08 06:11 am | N/A 2034-06-13 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Pierce Kristen Chief Development Officer | 0 | $0 | 659 (Direct) | View |
| 2025-03-31 Exercise | 2025-04-04 7:12 pm | 2025-02-07 N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 294,460 | $0.0001 | 707,524 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:18 pm | N/A 2035-03-03 | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 17,923 | $0 | 17,923 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:16 pm | N/A 2035-03-03 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director | 17,923 | $0 | 17,923 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:16 pm | N/A 2035-03-03 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director | 17,923 | $0 | 17,923 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:15 pm | N/A 2035-03-03 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director | 14,936 | $0 | 14,936 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:14 pm | N/A 2035-03-03 | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 14,936 | $0 | 14,936 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:10 pm | N/A 2035-03-03 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO | 119,486 | $0 | 119,486 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-26 6:06 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director | 127,500 | $0 | 255,000 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-26 6:03 pm | N/A 2034-10-10 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director | 127,500 | $0 | 255,000 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-26 6:02 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 127,500 | $0 | 255,000 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-26 5:59 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO | 1,275,000 | $0 | 2,550,000 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-26 5:57 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director | 127,500 | $0 | 255,000 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-26 5:54 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 254,000 | $0 | 508,000 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-07 5:23 pm | 2025-02-07 N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 510,200 | $0.0001 | 1,020,400 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-07 5:23 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 510,200 | $1.9599 | 1,020,400 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 9:13 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Chairman and CEO | 1,275,000 | $0 | 1,275,000 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 9:12 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director | 127,500 | $0 | 127,500 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 9:12 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 127,500 | $0 | 127,500 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 9:11 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director | 127,500 | $0 | 127,500 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 9:11 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 254,000 | $0 | 254,000 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 9:10 pm | N/A 2034-10-10 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director | 127,500 | $0 | 127,500 (Direct) | View |
Ownership | 2024-11-20 4:03 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | SLOAN STUART M 10% Owner | 0 | $0 | 21,600,442 (Indirect) | View |
Ownership | 2024-11-14 8:12 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | YK Bioventures Opportunities GP I LLC YK Bioventures Opportunities Fund I L.P. Kossar Mitchell William Yeung Gary Kahing 10% Owner | 0 | $0 | 25,870,783 (Indirect) | View |
Ownership | 2024-10-11 4:15 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director | 0 | $0 | 1,435,252 (Indirect) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 965,997 | $0 | 971,825 (Indirect) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 50 | $1000 | 971,825 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO | 5,312,983 | $0 | 5,795,408 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO | 275 | $1000 | 5,795,408 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:52 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 19,358,578 | $0 | 19,732,313 (Indirect) | View |
| 2024-09-25 Exercise | 2024-10-02 9:52 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 1,002 | $1000 | 19,732,313 (Indirect) | View |
| 2024-10-01 Option Award | 2024-10-02 7:03 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | KUCHARCHUK ANDREW ALBERT Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |